Larynx preservation and survival trends: should there be concern?
Forastiere
Arlene A
AA
Department of Oncology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA. af@jhmi.edu
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D019317:Evidence-Based Medicine; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D007825:Laryngectomy / Q000379:methods*; D009367:Neoplasm Staging; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D020127:Recovery of Function; D012074:Remission Induction / Q000379:methods; D018570:Risk Assessment; D016019:Survival Analysis